Annual EBITDA
$21.93 M
+$27.55 M+490.30%
31 December 2023
Summary:
Enfusion annual earnings before interest, taxes, depreciation & amortization is currently $21.93 million, with the most recent change of +$27.55 million (+490.30%) on 31 December 2023. During the last 3 years, it has risen by +$13.57 million (+162.22%). ENFN annual EBITDA is now at all-time high.ENFN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$5.94 M
+$365.00 K+6.55%
30 September 2024
Summary:
Enfusion quarterly earnings before interest, taxes, depreciation & amortization is currently $5.94 million, with the most recent change of +$365.00 thousand (+6.55%) on 30 September 2024. Over the past year, it has increased by +$730.00 thousand (+14.01%). ENFN quarterly EBITDA is now -12.98% below its all-time high of $6.83 million, reached on 30 June 2021.ENFN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$18.73 M
+$730.00 K+4.06%
30 September 2024
Summary:
Enfusion TTM earnings before interest, taxes, depreciation & amortization is currently $18.73 million, with the most recent change of +$730.00 thousand (+4.06%) on 30 September 2024. Over the past year, it has dropped by -$621.00 thousand (-3.21%). ENFN TTM EBITDA is now -14.63% below its all-time high of $21.93 million, reached on 31 December 2023.ENFN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENFN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +490.3% | +14.0% | -3.2% |
| 3 y3 years | +162.2% | +0.4% | +132.6% |
| 5 y5 years | - | - | - |
ENFN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +108.1% | -9.3% | +102.0% | -14.6% | +106.2% |
| 5 y | 5 years | at high | +108.1% | -13.0% | +102.0% | -14.6% | +106.2% |
| alltime | all time | at high | +108.1% | -13.0% | +102.0% | -14.6% | +106.2% |
Enfusion EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.94 M(+6.5%) | $18.73 M(+4.1%) |
| June 2024 | - | $5.58 M(+257.2%) | $18.00 M(+6.2%) |
| Mar 2024 | - | $1.56 M(-72.4%) | $16.95 M(-22.7%) |
| Dec 2023 | $21.93 M(-490.3%) | $5.65 M(+8.4%) | $21.93 M(+13.4%) |
| Sept 2023 | - | $5.21 M(+15.1%) | $19.35 M(+3.0%) |
| June 2023 | - | $4.53 M(-30.8%) | $18.78 M(+57.0%) |
| Mar 2023 | - | $6.55 M(+113.8%) | $11.96 M(-312.8%) |
| Dec 2022 | -$5.62 M | $3.06 M(-34.0%) | -$5.62 M(-98.1%) |
| Sept 2022 | - | $4.64 M(-302.5%) | -$299.89 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$2.29 M(-79.2%) | -$298.61 M(+3.1%) |
| Mar 2022 | - | -$11.03 M(-96.2%) | -$289.50 M(+6.5%) |
| Dec 2021 | -$271.91 M(-3350.6%) | -$291.21 M(-5019.9%) | -$271.91 M(-3476.9%) |
| Sept 2021 | - | $5.92 M(-13.3%) | $8.05 M(-9.7%) |
| June 2021 | - | $6.83 M(+4.1%) | $8.92 M(+326.8%) |
| Mar 2021 | - | $6.56 M(-158.3%) | $2.09 M(-146.7%) |
| Dec 2020 | $8.37 M(-44.3%) | -$11.25 M(-265.9%) | -$4.47 M(-165.9%) |
| Sept 2020 | - | $6.78 M | $6.78 M |
| Dec 2019 | $15.02 M | - | - |
FAQ
- What is Enfusion annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Enfusion?
- What is Enfusion annual EBITDA year-on-year change?
- What is Enfusion quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Enfusion?
- What is Enfusion quarterly EBITDA year-on-year change?
- What is Enfusion TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Enfusion?
- What is Enfusion TTM EBITDA year-on-year change?
What is Enfusion annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ENFN is $21.93 M
What is the all time high annual EBITDA for Enfusion?
Enfusion all-time high annual earnings before interest, taxes, depreciation & amortization is $21.93 M
What is Enfusion annual EBITDA year-on-year change?
Over the past year, ENFN annual earnings before interest, taxes, depreciation & amortization has changed by +$27.55 M (+490.30%)
What is Enfusion quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ENFN is $5.94 M
What is the all time high quarterly EBITDA for Enfusion?
Enfusion all-time high quarterly earnings before interest, taxes, depreciation & amortization is $6.83 M
What is Enfusion quarterly EBITDA year-on-year change?
Over the past year, ENFN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$730.00 K (+14.01%)
What is Enfusion TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ENFN is $18.73 M
What is the all time high TTM EBITDA for Enfusion?
Enfusion all-time high TTM earnings before interest, taxes, depreciation & amortization is $21.93 M
What is Enfusion TTM EBITDA year-on-year change?
Over the past year, ENFN TTM earnings before interest, taxes, depreciation & amortization has changed by -$621.00 K (-3.21%)